Received Oct 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | YE232 | IM / LA |
Patient received third dose of RSV vaccine. Previously received dose of Arexvy in 2024 and 2023. No negative effects reported.
None Known
None Known
None Known
NKA
None